IBM recently gained 1.37% to $285.87, outperforming the S&P 500 in the latest session, though it has lagged its sector over the past month. Ahead of its Q2 2025 earnings release on July 23, the company is projected to report an EPS of $2.64 (+8.64% YoY) and revenue of $16.58 billion (+5.13% YoY). Despite these growth forecasts, recent analyst estimate revisions have been slightly negative, contributing to a Zacks Rank #4 (Sell) and indicating the stock trades at a premium valuation with a Forward P/E of 25.77 and PEG ratio of 5.92, both above industry averages.
International Business Machines (IBM) presents a conflicting short-term outlook for investors. While the stock recently outperformed the S&P 500 with a 1.37% gain, its performance over the past month shows a 0.43% loss, significantly lagging the Computer and Technology sector's 7.44% gain. Forward-looking consensus estimates for its July 2025 earnings report are positive, projecting 8.64% year-over-year EPS growth to $2.64 and a 5.13% revenue increase to $16.58 billion. However, these growth expectations are undermined by several cautionary signals. Analyst sentiment has recently turned slightly negative, evidenced by a 0.03% decrease in the Zacks Consensus EPS estimate over the last 30 days, contributing to a bearish Zacks Rank of #4 (Sell). Furthermore, the company's valuation appears stretched, with a Forward P/E ratio of 25.77 and a PEG ratio of 5.92, both of which represent a significant premium to the industry averages of 19.71 and 4.21, respectively. This suggests the stock is priced richly relative to both its peers and its expected earnings growth rate, creating a challenging setup despite operating in an industry ranked in the top 21% of the market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment